Novartis Investigative Site

Girona, Catalonia 17007

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Cardiovascular Disease, Primary Progressive Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. — Stopped early
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early